Selecting the right tool for the job
- PMID: 25856591
- PMCID: PMC5572069
- DOI: 10.1080/15265161.2015.1010993
Selecting the right tool for the job
Abstract
There are competing ethical concerns when it comes to designing any clinical research study. Clinical trials of possible treatments for Ebola virus are no exception. If anything, the competing ethical concerns are exacerbated in trying to find answers to a deadly, rapidly spreading, infectious disease. The primary goal of current research is to identify experimental therapies that can cure Ebola or cure it with reasonable probability in infected individuals. Pursuit of that goal must be methodologically sound, practical and consistent with prevailing norms governing human subjects research. Some maintain that only randomized controlled trials (RCTs) with a placebo or standard-of-care arm can meet these conditions. We maintain that there are alternative trial designs that can do so as well and that sometimes these are preferable to RCTs.
Keywords: Ebola treatment trials; adaptive trial design; cluster randomized designs; compassionate access; elimination of inferior treatments; expanded access; international research; placebo controls; randomized controlled trials (RCT); research ethics; selection trials; sequential designs; standard of care controls.
Comment in
-
Right job, wrong tool: a commentary on designing clinical trials for Ebola virus disease.Am J Bioeth. 2015;15(4):33-6. doi: 10.1080/15265161.2015.1010018. Am J Bioeth. 2015. PMID: 25856596 No abstract available.
-
Controlling Ebola trials.Am J Bioeth. 2015;15(4):36-7. doi: 10.1080/15265161.2015.1009568. Am J Bioeth. 2015. PMID: 25856597 No abstract available.
-
Thoughts on alternative designs for clinical trials for Ebola treatment research.Am J Bioeth. 2015;15(4):38-40. doi: 10.1080/15265161.2015.1011001. Am J Bioeth. 2015. PMID: 25856598 No abstract available.
-
Expand the toolkit!Am J Bioeth. 2015;15(4):40-2. doi: 10.1080/15265161.2015.1009571. Am J Bioeth. 2015. PMID: 25856599 No abstract available.
-
Impure politics and pure science: efficacious Ebola medications are only a palliation and not a cure for structural disadvantage.Am J Bioeth. 2015;15(4):43-5. doi: 10.1080/15265161.2015.1009563. Am J Bioeth. 2015. PMID: 25856600 No abstract available.
-
Not all RCTs are created equal: lessons from early AIDS trials.Am J Bioeth. 2015;15(4):45-7. doi: 10.1080/15265161.2015.1010019. Am J Bioeth. 2015. PMID: 25856601 No abstract available.
-
The goals of research during an epidemic.Am J Bioeth. 2015;15(4):47-50. doi: 10.1080/15265161.2015.1009573. Am J Bioeth. 2015. PMID: 25856602 No abstract available.
-
Everyday ethics and Ebola: planning for the unlikely.Am J Bioeth. 2015;15(4):68-70. doi: 10.1080/15265161.2015.1010020. Am J Bioeth. 2015. PMID: 25856610 No abstract available.
-
The perfect must not overwhelm the good: response to open peer commentaries on "Selecting the right tool for the job".Am J Bioeth. 2015;15(4):W8-10. doi: 10.1080/15265161.2015.1023118. Am J Bioeth. 2015. PMID: 25856624 No abstract available.
References
-
- BBC. Ebola outbreak: Guinea health team killed. BBC News Africa. 2014 Sep 19; Available at: http://www.bbc.com/news/world-africa-29256443.
-
- Bechhofer RE. A single-sample multiple decision procedure for ranking means of normal populations with known variances. Annals of Mathematical Statistics. 1954;25:16–29. http://dx.doi.org/10.1214/aoms/1177728845. - DOI
-
- Bechhofer RE, Santner TJ, Goldsman DM. Design and analysis of experiments for statistical selection, screening, and multiple comparisons. New York, NY: John Wiley & Sons; 1995.
-
- Boseley S. Ebola: Experimental drug trials to go ahead in west Africa. The Guardian. 2014 Nov 13; Available at: http://www.theguardian.com/world/2014/nov/13/ebola-drug-trials-liberia-g....
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical